Paul Batty/LinkedIn
Sep 18, 2025, 09:15
Paul Batty: The Hepatic Odyssey of AAV Gene Therapy in Hemophilia
Paul Batty, Associate Professor at University College London and Honorary Consultant in Haemostasis and Thrombosis at the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, shared a post on X:
”Our educational review summarising the hepatic lifecycle of AAV gene therapy and how this is linked to treatment outcomes has been published in the Journal of Thrombosis and Haemostasis.”
Title: The Hepatic Odyssey of AAV: From Gene Delivery to Long-Term Outcomes
Authors: Giulia Simini, Paul Batty
Read the full article here.
Stay updated with Hemostasis Today.
-
Jun 11, 2026, 12:58Joseph R. Shaw: Beyond Predictable Pharmacokinetics in DOAC Therapy
-
Jun 11, 2026, 12:40Khechar N Paudel: The Nepal Stroke Project Brings Evidence-Based Stroke Care to Remote Communities
-
Jun 11, 2026, 12:35Sergey Badalyan: EHA2026 Opening Ceremony – The Importance of Building Communities, Not Projects
-
Jun 11, 2026, 12:15Welcome to EHA 2026
-
Jun 11, 2026, 08:35Mohamed Reda: CBC Report – More Than Just Numbers
-
Jun 11, 2026, 07:59Uday Sankar Akash Vankayala: Key Findings on IBD-Associated VTE Phenotypes and Inpatient Burden
-
Jun 11, 2026, 07:41Zia Ullah: Hidden Cerebral Venous Sinus Thrombosis After Dengue Recovery
-
Jun 11, 2026, 07:24Aaron Rodriguez Calienes: RESISTANT Registry Provides Reassuring Safety Data for Acute Intracranial Stenting
-
Jun 11, 2026, 07:17Mbunya. S. Misiani: From the WFH Congress to Meaningful Change for Patients with Bleeding Disorders Worldwide